BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35210813)

  • 1. Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis.
    Tang D; Zhang D; Heng Y; Zhu XK; Lin HQ; Zhou J; Tao L; Lu LM
    J Inflamm Res; 2022; 15():1079-1097. PubMed ID: 35210813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.
    Franz L; Alessandrini L; Fasanaro E; Gaudioso P; Carli A; Nicolai P; Marioni G
    Ann Diagn Pathol; 2021 Feb; 50():151657. PubMed ID: 33189034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance.
    Zhang D; Zhou J; Tang D; Zhou L; Chou L; Chou KY; Tao L; Lu LM
    Clin Immunol; 2017 Feb; 175():34-40. PubMed ID: 27876461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
    Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J
    Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Wang TT; Zhao YL; Peng LS; Chen N; Chen W; Lv YP; Mao FY; Zhang JY; Cheng P; Teng YS; Fu XL; Yu PW; Guo G; Luo P; Zhuang Y; Zou QM
    Gut; 2017 Nov; 66(11):1900-1911. PubMed ID: 28274999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer.
    Kwantwi LB; Wang S; Zhang W; Peng W; Cai Z; Sheng Y; Xiao H; Wang X; Wu Q
    Bioengineered; 2021 Dec; 12(1):6996-7006. PubMed ID: 34519637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8
    Ji Y; Heng Y; Zhu X; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
    Transl Oncol; 2024 Jul; 45():101936. PubMed ID: 38678970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of immune cell genetic variants associated with tumor microenvironment response in laryngeal squamous cell carcinoma (LSCC) in terms of clinicopathological features.
    Horozoglu C; Sonmez D; Demirkol S; Hakan MT; Kaleler I; Hepokur C; Verim A; Yaylim I
    Pathol Res Pract; 2021 Dec; 228():153665. PubMed ID: 34717150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma.
    Yang Z; Wang J; Chen C; Sun P; Yu Y
    Technol Cancer Res Treat; 2021; 20():15330338211046432. PubMed ID: 34632870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis.
    Sun R; Xiong Y; Liu H; Gao C; Su L; Weng J; Yuan X; Zhang D; Feng J
    Transl Oncol; 2020 Oct; 13(10):100825. PubMed ID: 32698059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity.
    Tian H; Shi G; Wang Q; Li Y; Yang Q; Li C; Yang G; Wu M; Xie Q; Zhang S; Yang Y; Xiang R; Yu D; Wei Y; Deng H
    Signal Transduct Target Ther; 2016; 1():16025. PubMed ID: 29263903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor associated neutrophils governs tumor progression through an IL-10/STAT3/PD-L1 feedback signaling loop in lung cancer.
    Zhang S; Sun L; Zuo J; Feng D
    Transl Oncol; 2024 Feb; 40():101866. PubMed ID: 38128466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma.
    Souza VG; Santos DJS; Silva AG; Ribeiro RIMA; Loyola AM; Cardoso SV; Miranda CSS; Cardoso LPV
    J Appl Oral Sci; 2022; 30():e20210344. PubMed ID: 35195152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade.
    Tachinami H; Nishii N; Xia Y; Kashima Y; Ohno T; Nagai S; Li L; Lau W; Tomihara K; Noguchi M; Azuma M
    Oral Oncol; 2019 Apr; 91():21-28. PubMed ID: 30926058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous cell carcinoma cell-derived GM-CSF regulates PD-L1 expression in tumor-associated macrophages through the JAK2/STAT3 signaling pathway.
    Wang P; Tao L; Yu Y; Wang Q; Ye P; Sun Y; Zhou J
    Am J Cancer Res; 2023; 13(2):589-601. PubMed ID: 36895967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer.
    Shi X; Zhang X; Li J; Zhao H; Mo L; Shi X; Hu Z; Gao J; Tan W
    Cancer Lett; 2017 Oct; 406():27-35. PubMed ID: 28797844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma.
    Alessandrini L; Franz L; Ottaviano G; Ghi MG; Lanza C; Blandamura S; Marioni G
    Oral Oncol; 2020 Sep; 108():104836. PubMed ID: 32512470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.